Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129740
Status:
COMPLETED
Last Update Posted:
2019-09-24
First Post:
2005-08-11
Brief Title:
Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia CML
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-11
First Submit QC Date:
August 11 2005
Study First Post Date:
2005-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-09-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-16
Last Update Post Date:
2019-09-24
Last Update Post Date Type:
ACTUAL